Amedisys, Inc. (NASDAQ:AMED) Sees Large Decrease in Short Interest

Amedisys, Inc. (NASDAQ:AMED) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 2,210,000 shares, a decrease of 14.7% from the November 30th total of 2,590,000 shares. Based on an average daily trading volume, of 539,400 shares, the short-interest ratio is presently 4.1 days. Approximately 6.9% of the shares of the stock are sold short.

Institutional Investors Weigh In On Amedisys

A number of institutional investors and hedge funds have recently modified their holdings of AMED. KBC Group NV purchased a new stake in shares of Amedisys during the 3rd quarter worth $63,000. Signaturefd LLC grew its position in shares of Amedisys by 88.2% in the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after buying an additional 530 shares during the last quarter. CWM LLC raised its stake in shares of Amedisys by 14.5% during the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after acquiring an additional 277 shares in the last quarter. Crossmark Global Holdings Inc. acquired a new stake in Amedisys in the third quarter valued at approximately $243,000. Finally, Intech Investment Management LLC purchased a new position in Amedisys in the second quarter worth $280,000. 94.36% of the stock is owned by institutional investors.

Amedisys Price Performance

Shares of NASDAQ AMED traded up $4.01 during mid-day trading on Friday, reaching $89.96. The company’s stock had a trading volume of 2,013,218 shares, compared to its average volume of 389,869. The firm has a market capitalization of $2.95 billion, a PE ratio of 35.70, a P/E/G ratio of 1.84 and a beta of 0.73. Amedisys has a 52 week low of $82.15 and a 52 week high of $98.95. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The stock has a fifty day moving average of $90.45 and a two-hundred day moving average of $94.43.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. During the same quarter in the prior year, the company posted $0.98 earnings per share. The firm’s revenue was up 5.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Amedisys will post 4.45 EPS for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.